Data / Drug companies / Kenvue Brands LLC
Kenvue Brands LLC: 143 products in the FDA NDC directory, labeler code 50580
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Kenvue Brands LLC (labeler code 50580) lists 143 products in the FDA National Drug Code Directory, covering 24 finished drugs by generic name. By type: 137 over the counter drugs, 6 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 1, 2026.
The request: Watch Kenvue Brands LLC (FDA labeler code 50580): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50580
- Products in commercial distribution
- 143
- Packages
- 363
- Finished drugs by generic name
- 24
- Prescription products
- 0
- Over the counter products
- 137
- Flagged as original packager
- 131 of 131 products that carry the flag
- Started marketing in the last 12 months
- 10
- Products with a marketing end date set
- 1
- Earliest marketing start
- August 19, 1984
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 97 | 67.8% |
| New drug applications (NDA) | 25 | 17.5% |
| Generic drugs (ANDA) | 15 | 10.5% |
| Drugs for further processing | 6 | 4.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 137 | 95.8% |
| Drugs for further processing | 6 | 4.2% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 40 | 214 |
| Cetirizine hydrochloride | 13 | 119 |
| Ibuprofen | 11 | 190 |
| Diphenhydramine hydrochloride | 10 | 127 |
| Acetaminophen and dextromethorphan hydrobromide | 4 | 6 |
| Acetaminophen, guaifenesin, and phenylephrine hydrochloride | 3 | 22 |
| Acetaminophen and phenylephrine hydrochloride | 3 | 13 |
| Loperamide hydrochloride | 3 | 82 |
| Oxymetazoline hydrochloride | 3 | 64 |
| Pseudoephedrine hydrochloride | 3 | 23 |
| Acetaminophen, dextromethorphan hydrobromide | 2 | 20 |
| Acetaminophen and diphenhydramine hydrochloride | 2 | 29 |
| Cetirizine hydrochloride and pseudoephedrine hydrochloride | 2 | 10 |
| Phenylephrine hydrochloride | 2 | 77 |
| Diclofenac sodium | 1 | 109 |
| Acetaminophen, diphenhydramine, pseudoephedrine | 1 | 1 |
| Acetaminophen and ibuprofen | 1 | 19 |
| Ibuprofen and phenylephrine hydrochloride | 1 | 1 |
| Loperamide hydrochloride and dimethicone | 1 | 1 |
| Acetaminophen, lidocaine, menthol | 1 | 1 |
| Naproxen sodium and pseudoephedrine hydrochloride | 1 | 3 |
| Ibuprofen and diphenhydramine citrate | 1 | 7 |
| Acetaminophen, guaifenesin | 1 | 6 |
| Acetaminophen, pseudoephedrine | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 41 | 28.7% |
| Suspension | 21 | 14.7% |
| Kit | 16 | 11.2% |
| Solution | 13 | 9.1% |
| Capsule, liquid filled | 9 | 6.3% |
| Tablet, chewable | 9 | 6.3% |
| Tablet, coated | 6 | 4.2% |
| Tablet, film coated, extended release | 6 | 4.2% |
| Tablet | 4 | 2.8% |
| Liquid | 4 | 2.8% |
| Spray | 3 | 2.1% |
| Powder | 2 | 1.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cetirizine | 50580-003 | Tablet, film coated | Drugs for further processing | October 1, 2026 |
| Extra Strength Tylenol Cold Plus Flu Multi-Symptom Day Night | 50580-585 | Kit | Over the counter monograph drugs | September 1, 2026 |
| Extra Strength TYLENOL Cold plus Flu Multi Symptom Day | 50580-586 | Tablet, film coated | Over the counter monograph drugs | June 18, 2026 |
| Extra Strength Tylenol Cold plus Flu Multi-Symptom Daytime | 50580-213 | Liquid | Over the counter monograph drugs | June 12, 2026 |
| Sudafed Sinus Congestion plus Cold Severe Day and Night | 50580-660 | Kit | Over the counter monograph drugs | June 10, 2026 |
| Sudafed Sinus Congestion Plus Cold Severe Day | 50580-659 | Tablet, film coated | Over the counter monograph drugs | June 10, 2026 |
| Extra Strength Tylenol Cold plus Flu Multi-Symptom Nighttime | 50580-212 | Liquid | Over the counter monograph drugs | June 1, 2026 |
| Infants TYLENOL | 50580-154 | Suspension | Over the counter monograph drugs | April 13, 2026 |
| Tylenol Cold Plus Flu Plus Chest Congestion | 50580-584 | Tablet, film coated | Over the counter monograph drugs | March 6, 2026 |
| TYLENOL Extra Strength | 50580-187 | Suspension | Over the counter monograph drugs | November 28, 2025 |
| Diphenhydramine hydrochloride | 50580-002 | Tablet, film coated | Drugs for further processing | November 1, 2025 |
| TYLENOL Extra Strength | 50580-469 | Capsule, liquid filled | Over the counter monograph drugs | October 27, 2025 |
| TYLENOL Extra Strength | 50580-108 | Tablet, film coated | Over the counter monograph drugs | October 13, 2025 |
| Diphenhydramine hydrochloride | 50580-001 | Tablet, film coated | Drugs for further processing | October 1, 2025 |
| Childrens TYLENOL | 50580-517 | Tablet, chewable | Over the counter monograph drugs | September 1, 2025 |
| TYLENOL Extra Strength | 50580-491 | Tablet, film coated | Over the counter monograph drugs | August 30, 2025 |
| TYLENOL Regular Strength | 50580-475 | Tablet, film coated | Over the counter monograph drugs | August 30, 2025 |
| TYLENOL Cold Plus Flu Multi-Symptom Liquid Gels Day Plus Night | 50580-141 | Kit | Over the counter monograph drugs | June 30, 2025 |
| SUDAFED OM Sinus Severe No Drip Nasal Mist with Cooling Menthol | 50580-368 | Spray | Over the counter monograph drugs | June 16, 2025 |
| SUDAFED OM Sinus Severe No Drip Nasal Mist | 50580-364 | Spray | Over the counter monograph drugs | June 16, 2025 |
| Extra Strength TYLENOL Severe Cough Plus Sore Throat Day | 50580-140 | Liquid | Over the counter monograph drugs | June 6, 2025 |
| ZYRTEC Hives | 50580-116 | Tablet, film coated | New drug applications (NDA) | June 2, 2025 |
| Benadryl Allergy Extra Strength Liqui-Gels | 50580-322 | Capsule, liquid filled | Over the counter monograph drugs | May 15, 2025 |
| Childrens tylenol | 50580-139 | Suspension | Over the counter monograph drugs | April 28, 2025 |
| Zyrtec hives | 50580-128 | Solution | New drug applications (NDA) | April 2, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.